Highlights Cochlear Limited

Equities

Market Closed - Australian S.E. Other stock markets 02:10:08 2024-06-25 EDT			5-day change	1st Jan Change
332.5 ^AUD	+2.71%		+0.11%	+11.33%

05-29	UK’s Competition Regulator Closes Cochlear-Demant Deal	MT
05-21	Cochlear Completes Acquisition of Oticon Medical's Cochlear Implant Business	MT

UK’s Competition Regulator Closes Cochlear-Demant Deal	05-29	MT
Cochlear Completes Acquisition of Oticon Medical's Cochlear Implant Business	05-21	MT
Cochlear Limited acquired Oticon Medical A/s from Demant A/S.	05-20	CI
Cochlear Limited Receives Fda Clearance to Lower the Age for the Osia System to 5-Year-Old	04-19	CI
Competition Regulator Clears Cochlear’s Acquisition of Oticon Medical’s Cochlear Implant Business	04-03	MT
Miners, healthcare firms push Australia stocks higher	03-25	RE
Ex-dividend day for interim dividend	03-20	FA
Sensorion: study results in hearing loss	03-11	CF
Cochlear's Revenue Soars on Sales Growth	02-19	MT
Cochlear Shares Slip 2%; Expects 26% Rise in Full Year Net Profit After Increase in H1 FY24 Profit, Revenue	02-18	MT
Cochlear Posts Rise in H1 FY24 Profit, Revenue	02-18	MT
Tranche Update on Cochlear Limited's Equity Buyback Plan announced on February 15, 2023.	02-18	CI
Cochlear Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-18	CI
Australian shares post first weekly fall in three as rate-hike bets back in focus	02-09	RE
Cochlear Upgrades Fiscal 2024 Profit Guidance; Shares Up 5%	02-07	MT
European Commission OKs Cochlear's Aquisition of Oticon Medical Unit	23-10-10	MT
Final dividend	23-09-17	FA
Cochlear Limited Introduces Next Generation Cochlear Osia System with Ability to Have MRI at 3.0 T	23-08-18	CI
Cochlear Grows Fiscal 2023 Profit, Revenue; Shares Jump 6%	23-08-14	MT
Cochlear Limited Provides Earnings Guidance for the Fiscal Year 2024	23-08-14	CI

No results for this search